HUL challenges Rs 962-crore tax demand for Rs 3,000-crore GSK deal

Hindustan Unilever Limited (HUL) has filed an appeal with the Commissioner of Income Tax to challenge the Rs 962 crore tax demand related to its acquisition of the ‘Horlicks’ brand from GlaxoSmithKline (GSK).

By  Storyboard18Oct 16, 2024 3:03 PM
HUL challenges Rs 962-crore tax demand for Rs 3,000-crore GSK deal
HUL completed the merger of GSK Consumer Healthcare with itself, and acquired Horlicks brand for India from GSK for Rs 3,045 crore, in April 2020.(Image source: Moneycontrol)

Within two months of receiving a tax notice of Rs 962.75 crore related to its acquisition of the ‘Horlicks’ brand from GlaxoSmithKline (GSK), Hindustan Unilever Limited (HUL) has filed an appeal with the Commissioner of Income Tax.

In August, HUL announced of received a tax notice of Rs 962.75 crore, including an interest of Rs 329.33 crore.

In its exchange filing then, the FMCG firm announced that the demand has been issued for the non-deduction of tax deducted at source for a remittance of Rs 3,045 crore for the payment towards the purchase of India Health Food Drink (HFD) Intellectual Property Rights (IPR) from GSK Group entities.

The company now has challenged the tax demand and has also applied for a stay of demand and requested a pause on penalty proceedings.

In its recent exchange filings, dated September 24, HUL mentioned initiating steps to invoke indemnification from GSK for the tax notices, stating it does not foresee any material financial implications at this stage.

HUL completed the merger of GSK Consumer Healthcare with itself, and acquired Horlicks brand for India from GSK for Rs 3,045 crore, in April 2020. With the same, HUL took ownership of the brands including Boost, Maltova and Viva.

It is to be noted that the tax department issued HUL a notice on October 7, 2022, seeking capital gains tax on the transaction.

Recently, on September 23, the Bombay High Court dismissed a writ petition filed by HUL seeking protection from these tax notices, on account of the company having statutory remedy of an appeal against the assessment order.

The HUL-GSK case mirrors the whole dispute and grey area in the Indian tax law on whether the sale of intellectual property (IP) should be taxed in the country where the IP is held or in the country where it is used.


Tags
First Published on Oct 16, 2024 3:03 PM

More from Storyboard18

How it Works

Raymond delivers highest annual revenue of Rs 9,286 crore

Raymond delivers highest annual revenue of Rs 9,286 crore

How it Works

86 percent consumers spend considerable time deciding what to watch next: Report

86 percent consumers spend considerable time deciding what to watch next: Report

How it Works

Blue Star Q4 results: Revenue jumps 26.8 percent to Rs 3,327.77 crore

Blue Star Q4 results: Revenue jumps 26.8 percent to Rs 3,327.77 crore

How it Works

Alphabet paid $20 billion to Apple to maintain its status as the default search engine

Alphabet paid $20 billion to Apple to maintain its status as the default search engine

How it Works

Honda Cars registers total sales of 10,867 units in April

Honda Cars registers total sales of 10,867 units in April

How it Works

LS Elections 2024: Rs 100 crore invested in AI integration in political campaigns

LS Elections 2024: Rs 100 crore invested in AI integration in political campaigns

How it Works

D2C Homeware brand ellementry secures funding from She Capital

D2C Homeware brand ellementry secures funding from She Capital

How it Works

India's online consumer spending expected to reach $300 Bn by 2030: Elevation Capital report

India's online consumer spending expected to reach $300 Bn by 2030: Elevation Capital report